Acasti Pharma reported $19.21M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acasti Pharma USD 19.21M 1.91M Dec/2025
Addus HomeCare USD 272.88M 3.38M Mar/2026
Amarin USD 626.02M 23.87M Mar/2026
Cassava Sciences USD 87.96M 9.74M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Option Care Health USD 1.2B 69.86M Mar/2026
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Tilray USD 729.32M 28.18M Sep/2025